Cargando…

A Subset of PD-1-Expressing CD56(bright) NK Cells Identifies Patients with Good Response to Immune Checkpoint Inhibitors in Lung Cancer

SIMPLE SUMMARY: In recent years, studies in cancer immunotherapy have focused on finding predictive response biomarkers to anticipate which patients will respond to each kind of treatment, optimizing treatment strategy and reducing toxicities and costs. Unfortunately, these studies are still limited...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gascón-Ruiz, Marta, Ramírez-Labrada, Ariel, Lastra, Rodrigo, Martínez-Lostao, Luis, Paño-Pardo, J. Ramón, Sesma, Andrea, Zapata-García, María, Moratiel, Alba, Quílez, Elisa, Torres-Ramón, Irene, Yubero, Alfonso, Domingo, María Pilar, Esteban, Patricia, Gálvez, Eva M., Pardo, Julián, Isla, Dolores
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856517/ https://www.ncbi.nlm.nih.gov/pubmed/36672279 http://dx.doi.org/10.3390/cancers15020329

Ejemplares similares

From Tumor Mutational Burden to Blood T Cell Receptor: Looking for the Best Predictive Biomarker in Lung Cancer Treated with Immunotherapy
por: Sesma, Andrea, et al.
Publicado: (2020)

Microbiota and Lung Cancer. Opportunities and Challenges for Improving Immunotherapy Efficacy
por: Ocáriz-Díez, Maitane, et al.
Publicado: (2020)

Intratumoral versus Circulating Lymphoid Cells as Predictive Biomarkers in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Is the Easiest Path the Best One?
por: Gascón, Marta, et al.
Publicado: (2020)

Reduction of the CD16(−)CD56(bright) NK Cell Subset Precedes NK Cell Dysfunction in Prostate Cancer
por: Koo, Kyo Chul, et al.
Publicado: (2013)

NK cells CD56(bright) and CD56(dim) subset cytokine loss and exhaustion is associated with impaired survival in myeloma
por: Seymour, Frances, et al.
Publicado: (2022)

Oncolytic virus treatment differentially affects the CD56(dim) and CD56(bright) NK cell subsets in vivo and regulates a spectrum of human NK cell activity
por: Wantoch, Michelle, et al.
Publicado: (2022)

Decidual CXCR4(+)CD56(bright)NK cells as a novel NK subset in maternal–foetal immune tolerance to alleviate early pregnancy failure
por: Tao, Yu, et al.
Publicado: (2021)

The Increased Ratio of Blood CD56(bright) NK to CD56(dim) NK Is a Distinguishing Feature of Primary Sjögren's Syndrome
por: Ming, Bingxia, et al.
Publicado: (2020)

Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56(bright)CD16(−) subset
por: Veneziani, Irene, et al.
Publicado: (2022)

The Multifaceted Function of Granzymes in Sepsis: Some Facts and a Lot to Discover
por: Garzón-Tituaña, Marcela, et al.
Publicado: (2020)

Diagnosis of Malnutrition According to GLIM Criteria Predicts Complications and 6-Month Survival in Cancer Outpatients
por: Gascón-Ruiz, Marta, et al.
Publicado: (2022)

Ageing is associated with a decline in peripheral blood CD56(bright )NK cells
por: Chidrawar, Shivani M, et al.
Publicado: (2006)

Circulating CD56(bright) NK cells inversely correlate with survival of melanoma patients
por: de Jonge, Kaat, et al.
Publicado: (2019)

Correction: Toll-like reReceptor 8 agonists improve NK-cell function primarily targeting CD56(bright)CD16(−) subset
Publicado: (2022)

PD-1 is expressed in cytotoxic granules of NK cells and rapidly mobilized to the cell membrane following recognition of tumor cells
por: Pesini, Cecilia, et al.
Publicado: (2022)

The co-inhibitory receptor TIGIT regulates NK cell function and is upregulated in human intrahepatic CD56(bright) NK cells
por: Ziegler, Annerose E., et al.
Publicado: (2023)

The CXCR3(+)CD56Bright Phenotype Characterizes a Distinct NK Cell Subset with Anti-Fibrotic Potential That Shows Dys-Regulated Activity in Hepatitis C
por: Eisenhardt, Marianne, et al.
Publicado: (2012)

Redistribution and Activation of CD16brightCD56dim NK Cell Subset to Fight against Omicron Subvariant BA.2 after COVID-19 Vaccination
por: Peng, Huiyun, et al.
Publicado: (2023)

Single-cell profiling reveals periventricular CD56(bright) NK cell accumulation in multiple sclerosis
por: Rodríguez-Lorenzo, Sabela, et al.
Publicado: (2022)

PILRα binds an unknown receptor expressed primarily on CD56(bright) and decidual-NK cells and activates NK cell functions
por: Ophir, Yael, et al.
Publicado: (2016)

Hobit expression by a subset of human liver-resident CD56(bright) Natural Killer cells
por: Lunemann, Sebastian, et al.
Publicado: (2017)

Loss of CCR7 Expression on CD56(bright) NK Cells Is Associated with a CD56(dim)CD16(+) NK Cell-Like Phenotype and Correlates with HIV Viral Load
por: Hong, Henoch S., et al.
Publicado: (2012)

Ovarian Cancer-Associated Ascites Have High Proportions of Cytokine-Responsive CD56bright NK Cells
por: Tonetti, Cláudia Rodrigues, et al.
Publicado: (2021)

Regulation of Development of CD56(bright)CD11c(+) NK-like Cells with Helper Function by IL-18
por: Li, Wen, et al.
Publicado: (2013)

Staphylococcus aureus β-Hemolysin Up-Regulates the Expression of IFN-γ by Human CD56(bright) NK Cells
por: Guan, Zhangchun, et al.
Publicado: (2021)

KLRF1, a novel marker of CD56(bright) NK cells, predicts improved survival for patients with locally advanced bladder cancer
por: Mukherjee, Neelam, et al.
Publicado: (2022)

Recalling the Biological Significance of Immune Checkpoints on NK Cells: A Chance to Overcome LAG3, PD1, and CTLA4 Inhibitory Pathways by Adoptive NK Cell Transfer?
por: Lanuza, Pilar M., et al.
Publicado: (2020)

Alterations in the CD56(−) and CD56(+) T Cell Subsets during COVID-19
por: Vavilova, Julia D., et al.
Publicado: (2023)

Increased CD56(bright) NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype
por: Bhardwaj, Suvercha, et al.
Publicado: (2016)

Distinct Signatures in the Receptor Repertoire Discriminate CD56bright and CD56dim Natural Killer Cells
por: Schwane, Vera, et al.
Publicado: (2020)

Integrated analysis of circulating immune cellular and soluble mediators reveals specific COVID19 signatures at hospital admission with utility for prediction of clinical outcomes
por: Uranga-Murillo, Iratxe, et al.
Publicado: (2022)

Human Natural Killer Cell Maturation Defect Supports In Vivo CD56(bright) to CD56(dim) Lineage Development
por: Domaica, Carolina Inés, et al.
Publicado: (2012)

Increased expression of TIGIT and KLRG1 correlates with impaired CD56(bright) NK cell immunity in HPV16-related cervical intraepithelial neoplasia
por: Nie, You, et al.
Publicado: (2022)

Haploidentical Stem Cell Transplantation in Children With Hematological Malignancies Using αβ(+) T-Cell Receptor and CD19(+) Cell Depleted Grafts: High CD56(dim)/CD56(bright) NK Cell Ratio Early Following Transplantation Is Associated With Lower Relapse Incidence and Better Outcome
por: Diaz, Miguel A., et al.
Publicado: (2019)

Integration of In Silico and In Vitro Analysis of Gliotoxin Production Reveals a Narrow Range of Producing Fungal Species
por: Redrado, Sergio, et al.
Publicado: (2022)

Expansion of CD56(dim)CD16(neg) NK Cell Subset and Increased Inhibitory KIRs in Hospitalized COVID-19 Patients
por: Casado, José L., et al.
Publicado: (2021)

Single-cell transcriptomics in bone marrow delineates CD56(dim)GranzymeK(+) subset as intermediate stage in NK cell differentiation
por: Melsen, Janine E., et al.
Publicado: (2022)

Tonsillar CD56brightNKG2A+ NK cells restrict primary Epstein-Barr virus infection in B cells via IFN-γ
por: Jud, Aurelia, et al.
Publicado: (2016)

Human Hepatic CD56(bright) NK Cells Display a Tissue-Resident Transcriptional Profile and Enhanced Ability to Kill Allogenic CD8(+) T Cells
por: Jameson, Gráinne, et al.
Publicado: (2022)

Evaluation of CD56(dim) and CD56(bright) natural killer cells in peripheral blood of women with IVF failures
por: Mardanian, Farahnaz, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_gbhkemjgm4533f07f6mqje858c